Cargando…
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration
Infantile hemangiomas (IHs) are the most common benign tumors in early childhood. They show a distinctive mechanism of tumor growth in which a rapid proliferative phase is followed by a regression phase (involution). Propranolol is an approved treatment for IHs, but its mechanism of action remains u...
Autores principales: | Gomez-Acevedo, Horacio, Dai, Yuemeng, Strub, Graham, Shawber, Carrie, Wu, June K., Richter, Gresham T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039967/ https://www.ncbi.nlm.nih.gov/pubmed/32094357 http://dx.doi.org/10.1038/s41598-020-60025-2 |
Ejemplares similares
-
Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development
por: Giese, Rachel A., et al.
Publicado: (2021) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)